Should you buy Integra LifeSciences Holdings C (IART)?
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Engine methodology range
Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.
What the engine is tracking
- Perfect Earnings Beat Streak→Stable
- Attractive Valuation Cheap Multiples→Stable
- Limited Upside Near 52 Week High→Stable
- +2 more pillars — see the Why tab for full reasoning
→ Full pillar scorecard with all 5 pillars + per-dimension breakdown
When this thesis breaks
Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Perfect Earnings Beat Streak
Trip ifThe upcoming quarterly earnings miss consensus estimates by more than 5%, breaking the current 4-quarter beat streak.
- P2Attractive Valuation Cheap Multiples
Trip ifPrice falls more than 15% without a corresponding cut to earnings estimates, showing the cheap multiple failed to re-rate.
- P3Limited Upside Near 52 Week High
Trip ifAnalyst price target is raised by more than 15%, or the asymmetry ratio turns positive above 0.5, reopening meaningful upside.
- P4Leverage Penalty And Weak Momentum
Trip ifDebt-to-equity ratio falls below 1.0 and momentum score rises above 4.5, resolving both concerns.
- P5Elevated Put Call And Short Interest
Trip ifShort interest falls below 5% of float and the put/call ratio drops below 0.7, easing the bearish positioning.
How the engine reached this verdict
TrendMatrix's engine output for Integra LifeSciences Holdings C (IART) is HOLD_IF_HOLDING with medium conviction, score 5.6/10 at $17.30. The F-path SELL output reflects an overall score of 4.6 below the 5.4 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. Asymmetry R:R of -1.38 is supplementary context, not the trigger.
On the bull side: Strong earnings beat streak (4/4); Positive news sentiment (+0.67); Earnings estimates trending UP. On the bear side: Concentration risk — Product: CSS segment (70.0%); Analyst target reached - limited upside remaining; Leverage penalty (D/E 2.0): -1.0. Active engine warnings: V8: Target reached (-12.4% upside), L3:NEWS_MOD=+2: SELL_IF_HOLDING → HOLD_IF_HOLDING, V9 Gate Failed: MOMENTUM:2.8<4.5.
The engine is not issuing fresh-money entry targets at the current verdict. The technical entry zone is around — with a technical stop near $16.25 for existing positions. Asymmetric R:R is -1.38, below the threshold (≥2.0) at which the engine would actively flag fresh capital. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).
HOLD flips toward BUY_WAIT if momentum at 2.8 vs threshold 4.5 clears AND a co-confirming gate triggers. HOLD flips toward SELL if any of the currently-passing gates drop below threshold OR three or more dimensions fall below 4 simultaneously.
For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates IART — 10-dimension breakdown →
Bull case
- ▸Strong earnings beat streak (4/4)
- ▸Positive news sentiment (+0.67)
- ▸Earnings estimates trending UP
Bear case
- ▸Concentration risk — Product: CSS segment (70.0%)
- ▸Analyst target reached - limited upside remaining
- ▸Leverage penalty (D/E 2.0): -1.0